Springer Nature
Browse
13104_2015_1292_MOESM1_ESM.ppt (141 kB)

Additional file 1: of Assessment of adverse events via a telephone consultation service for cancer patients receiving ambulatory chemotherapy

Download (141 kB)
presentation
posted on 2015-07-26, 05:00 authored by Shunsuke Kondo, Satoshi Shiba, Ryoko Udagawa, Yasuaki Ryushima, Miho Yano, Tomoko Uehara, Mihoko Asanabe, Kenji Tamura, Jun Hashimoto
Figure S1. A) Common adverse events reported during consultation. B) Chemotherapy regimens of patients using the telephone consultation service. AC; adriamycin + cyclophosphamide, CBDCA; carboplatin, PTX; paclitaxel, GEM; gemcitabine, CEF; cyclophosphamide + epirubicine + 5-FU, CDDP; cisplatin, BV; bevacizumab.

History

Usage metrics

    BMC Research Notes

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC